Medical Condition News

RSS

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.

10 Sep 2013

MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

Rhythm announced today that The Michael J. Fox Foundation for Parkinson's Research has awarded a $1.35 million research grant to Rhythm to help fund a Phase 2 clinical trial of RM-131, the company's novel ghrelin agonist, for the treatment of refractory constipation in patients with Parkinson's disease.

10 Sep 2013

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.

10 Sep 2013

Screening older people for minor memory changes may lead to harmful treatment

A political drive, led by the UK and US, to screen older people for minor memory changes (often called mild cognitive impairment or pre-dementia) is leading to unnecessary investigation and potentially harmful treatment for what is arguably an inevitable consequence of ageing, warn University of Sydney experts in in a paper published in the British Medical Journal today.

10 Sep 2013

New Atkins Candies help dieters satisfy their sweet tooth with low-carb option

Low-carb dieters now have an even sweeter way to melt off the pounds. Atkins Nutritionals, Inc., a leader in the weight-management category, announced today the launch of Atkins™ Candies, an indulgent line of bite-sized snacks that will be available nationwide beginning October 2013.

10 Sep 2013

Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

Power Balance Technologies Inc., sellers of the original Power Balance silicone wristband, today announces their year-long partnership with the National Breast Cancer Foundation, Inc. (NBCF) with the new 'Breast Cancer Awareness' Wristband.

10 Sep 2013

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

UL licenses new optical fibre technology to Pointec Medical

The University of Limerick recently licensed a ground breaking new technology based on optical fibres to the Galway based medical devices company, Pointec Medical Ltd.

10 Sep 2013

New study reveals evaluation results of national anti-smoking campaign in USA

A comprehensive evaluation of the first ever federally-funded national smoking cessation campaign in the USA has revealed that the campaign may have helped at least 100 000 people in the USA to give up smoking, according to new results published in The Lancet.

10 Sep 2013

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of new approaches in pharmaco-imaging.

10 Sep 2013

Drug can be delivered safely to people with COPD in both "mist" and "dry powder" inhalers, say experts

An international study led by a Johns Hopkins pulmonary expert finds that the drug tiotropium (marketed as the Spiriva brand), can be delivered safely and effectively to people with chronic obstructive pulmonary disease (COPD) in both "mist" and traditional "dry powder" inhalers.

10 Sep 2013

Studies suggest need for more research to better understand caffeine addiction

Studies have shown that caffeine users can become dependent on or addicted to caffeine and may have difficulty reducing their consumption, as can occur with other drugs of dependence. A comprehensive review of the current evidence on caffeine dependence is presented in an article in Journal of Caffeine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

10 Sep 2013

Parasites could be potential key to treating autoimmune diseases

There is a new weapon in the fight against autoimmune diseases such as Type 1 diabetes, rheumatoid arthritis, Crohn's disease and lupus, the common trait of which is an immune system that attacks its own organs and tissues.

10 Sep 2013

Novel viral therapy to treat specific types of cancer in children

Parents do everything they can to protect their children against all of the nasty germs floating around classrooms across the country this time of year. Doctors and researchers at Nationwide Children's Hospital, however, are looking into how those same types of common viruses can actually help treat a child who is diagnosed with certain cancers.

10 Sep 2013

DO-HEALTH study aims to provide evidence for strategies that prevent chronic disease in seniors

Europe's largest healthy ageing study - DO-HEALTH - which aims to provide evidence for the safety of three simple preventive interventions: vitamin D, omega-3 fatty acids and a simple home exercise programme, has recruited 532 of its target 2,000 seniors.

10 Sep 2013

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

A research team at Cold Spring Harbor Laboratory has used a recently developed technology they call TSUNAMI to create the first animal model of the adult-onset version of spinal muscular atrophy, a devastating motor-neuron illness.

10 Sep 2013

Most patients who report statin intolerance can actually tolerate drugs on subsequent trials

Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from Cleveland Clinic recently released online and forthcoming in the September issue of the American Heart Journal. The study is the largest ever to examine the effects of re-challenging statin-intolerant patients.

10 Sep 2013

Research offers focused explanation for cardiac arrest predilection for morning hours

Evidence from people with heart disease strongly supports the existence of the molecular link first discovered in laboratory mice between the body's natural circadian rhythms and cardiac arrest or sudden cardiac death (SCD) - the No. 1 cause of death in heart attacks, a scientist said here today.

10 Sep 2013

Exposure to fumes released during firing of military small arms can lead to decline in lung function

Exposure to fumes released during the firing of military small arms can lead to a decline in lung function, according to a new study.

10 Sep 2013

Scientists take major step towards treatment for heart attack

A team of scientists at Karolinska Institutet and Harvard University has taken a major step towards treatment for heart attack, by instructing the injured heart in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.

10 Sep 2013

Medical Condition News

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Screening older people for minor memory changes may lead to harmful treatment

New Atkins Candies help dieters satisfy their sweet tooth with low-carb option

Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

Patients with COPD show improvements in lung function with olodaterol

UL licenses new optical fibre technology to Pointec Medical

New study reveals evaluation results of national anti-smoking campaign in USA

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Drug can be delivered safely to people with COPD in both "mist" and "dry powder" inhalers, say experts

Studies suggest need for more research to better understand caffeine addiction

Parasites could be potential key to treating autoimmune diseases

Novel viral therapy to treat specific types of cancer in children

DO-HEALTH study aims to provide evidence for strategies that prevent chronic disease in seniors

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

Most patients who report statin intolerance can actually tolerate drugs on subsequent trials

Research offers focused explanation for cardiac arrest predilection for morning hours

Exposure to fumes released during firing of military small arms can lead to decline in lung function

Scientists take major step towards treatment for heart attack

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News